deferoxamine has been researched along with hydroxyproline in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (45.45) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harwood, R; Hunt, J; Jacobs, A; Richards, RJ | 1 |
| Chandler, DB; Fulmer, JD; Jackson, RM; Kennedy, JI | 1 |
| Borel, JP; Ferradini, C; Gardès-Albert, M; Monboisse, JC; Randoux, A | 1 |
| Aloia, J; Yeh, JK; Zaino, EC | 1 |
| Chvapil, M; Madden, JW; McCarthy, D; Peacock, EE | 1 |
| Ecelbarger, CA; Greger, JL; MacNeil, GG | 1 |
| Cardillo, T; Davis, CS; Dreicer, R; Forest, PK; Kemp, JD; See, WA; Stegink, LD | 1 |
| Gaskell, SJ; Gielbert, J; Hebestreit, HF; Jaakkola, P; Maxwell, PH; Mole, DR; Mukherji, M; Pugh, CW; Ratcliffe, PJ; Schofield, CJ; Tian, YM; von Kriegsheim, A; Wilson, MI | 1 |
| Asara, JM; Ivan, M; Kaelin , WG; Kim, W; Kondo, K; Lane, WS; Ohh, M; Salic, A; Valiando, J; Yang, H | 1 |
| Churg, A; Dai, J; Vincent, R; Xie, C | 1 |
| Anagha, S; Aneesha, VA; Dar, JA; Kumar, D; Kumar, P; Qayoom, A | 1 |
1 trial(s) available for deferoxamine and hydroxyproline
| Article | Year |
|---|---|
A phase II trial of deferoxamine in patients with hormone-refractory metastatic prostate cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Creatinine; Deferoxamine; Drug Resistance, Neoplasm; Humans; Hydroxyproline; Infusions, Intravenous; Lung Neoplasms; Lymphatic Metastasis; Male; Methylhistidines; Middle Aged; Pelvis; Prostatic Neoplasms | 1997 |
10 other study(ies) available for deferoxamine and hydroxyproline
| Article | Year |
|---|---|
The effect of desferrioxamine on fibroblasts and collagen formation in cell cultures.
Topics: Cell Division; Cells, Cultured; Collagen; Deferoxamine; DNA; Fibroblasts; Hydroxyproline | 1979 |
Reduction in bleomycin-induced lung hydroxyproline content by an iron chelating agent.
Topics: Animals; Bleomycin; Chelating Agents; Cricetinae; Deferoxamine; Hydroxyproline; Iron; Lung; Male; Mesocricetus; Oxygen; Pulmonary Fibrosis; Rats | 1986 |
Collagen degradation by superoxide anion in pulse and gamma radiolysis.
Topics: Animals; Anions; Cattle; Cobalt Radioisotopes; Collagen; Deferoxamine; Gamma Rays; Hydroxyproline; Kinetics; Pentetic Acid; Peptide Fragments; Pulse Radiolysis; Skin; Spectrum Analysis; Superoxide Dismutase; Superoxides | 1988 |
Defective vitamin D metabolism in thalassemia major.
Topics: Adolescent; Adult; Calcitriol; Calcium; Chelating Agents; Child; Child, Preschool; Deferoxamine; Ergocalciferols; Female; Humans; Hydroxyproline; Iron; Liver; Male; Parathyroid Hormone; Phosphorus; Thalassemia; Vitamin D | 1985 |
Effect of 1,10-phenanthroline and desferrioxamine in vivo on prolyl hydroxylase and hydroxylation of collagen in various tissues of rats.
Topics: Animals; Animals, Newborn; Body Weight; Calcium; Carrageenan; Collagen; Deferoxamine; Estradiol; Female; Fetus; Gestational Age; Granuloma; Hydrogen-Ion Concentration; Hydroxylation; Hydroxyproline; Intestines; Iron; Iron Chelating Agents; Liver; Organ Size; Phenanthrolines; Pregnancy; Procollagen-Proline Dioxygenase; Proline; Rats; Skin; Tritium; Uterus | 1974 |
Aluminum retention by aged rats fed aluminum and treated with desferrioxamine.
Topics: Aging; Aluminum; Analysis of Variance; Animals; Bone Remodeling; Deferoxamine; Hydroxyproline; Male; Rats; Rats, Sprague-Dawley; Tissue Distribution | 1994 |
Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.
Topics: Amino Acid Sequence; Ascorbic Acid; Cell Hypoxia; Deferoxamine; DNA-Binding Proteins; Ferrous Compounds; Humans; Hydroxylation; Hydroxyproline; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Ligases; Molecular Sequence Data; Nuclear Proteins; Oxygen; Point Mutation; Procollagen-Proline Dioxygenase; Protein Structure, Tertiary; Proteins; Recombinant Fusion Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Ubiquitins; Von Hippel-Lindau Tumor Suppressor Protein | 2001 |
HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.
Topics: Amino Acid Sequence; Animals; Basic Helix-Loop-Helix Transcription Factors; Cell Hypoxia; Cell Line; Cobalt; Deferoxamine; Humans; Hydroxylation; Hydroxyproline; Ligases; Mass Spectrometry; Mice; Molecular Sequence Data; Oxygen; Protein Structure, Tertiary; Proteins; Recombinant Fusion Proteins; Trans-Activators; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Ubiquitins; Von Hippel-Lindau Tumor Suppressor Protein | 2001 |
Air pollution particles produce airway wall remodeling in rat tracheal explants.
Topics: Air Pollution; alpha-Fetoproteins; Animals; Cells, Cultured; Chelating Agents; Collagen; Deferoxamine; DNA, Complementary; Enzyme Inhibitors; Fibrosis; Flavonoids; Gene Expression Regulation; Hydroxyproline; Imidazoles; Iron; Mitogen-Activated Protein Kinases; NF-kappa B; Organ Culture Techniques; Oxidants; p38 Mitogen-Activated Protein Kinases; Peptides; Procollagen; Promoter Regions, Genetic; Pyridines; Rats; Thiourea; Time Factors; Trachea; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2003 |
Lecithin-based deferoxamine nanoparticles accelerated cutaneous wound healing in diabetic rats.
Topics: Animals; Chemokine CXCL12; Collagen; Deferoxamine; Diabetes Mellitus, Experimental; Drug Carriers; Glucosamine; Hydroxyproline; Hypoxia-Inducible Factor 1, alpha Subunit; Interleukin-10; Kinetics; Lecithins; Male; Nanoparticles; Neovascularization, Physiologic; Rats; Rats, Wistar; Skin; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Wound Healing | 2019 |